The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you whenever you need it. Give us a call at 650-498-3333 or GuestServices@stanfordmed.org.
PHYSICIAN HELPLINE
Have a question? We're here to help!
Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Caroline Berube
Hematologist, Medical oncologist, Leukemia specialist
Clinical Associate Professor, Medicine - Hematology
- 875 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-498-6000
- 875 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-498-6000
- 900 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-725-4932
Conditions Treated
Professional Overview
Professional Education
Board Certification: Medical Oncology, Royal College of Physicians and Surgeons of Canada (1990)
Board Certification: Hematology, Royal College of Physicians and Surgeons (1989)
Board Certification: Internal Medicine, Royal College of Physicians and Surgeons of Canada (1988)
Residency: Laval University (1987) Canada
Internship: Laval University (1984) Canada
Fellowship: McMaster University (1991) Canada
Fellowship: The University of British Columbia (1990) Canada
Oncology, University of BC, Canada, Medical Oncology (1990)
Board certification, Hematology, Canadian Hematology Board (1989)
Fellowship: University of Montreal (1989) Canada
Hematology, University of Montreal, Canada, Hematology (1989)
Medical Education: Laval University (1983) Canada
F.R.C.P.(C), Internal Medicine, Canadian Board (1987)
M.D., Laval University, Canada, Medicine (1984)
Administrative Appointments
Medical Director, Oral Anticoagulation Clinic, Stanford Hospital and Clinics (2004 - Present)
Patient Ratings and Comments
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Publications
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
Pollyea, D. A., Zehnder, J., Coutre, S., Gotlib, J. R., Gallegos, L., & Medeiros, B. C. (2013). Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia. HAEMATOLOGICA, 98(4), 591-596.
Accessory splenules in autoimmune hemolytic anemia.
Logan, A., Berube, C., & Gotlib, J. (2013). Accessory splenules in autoimmune hemolytic anemia. American journal of hematology, 88(2), 156-?.
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
Pollyea, D. A., Kohrt, H. E., Gallegos, L., Figueroa, M. E., Abdel-Wahab, O., & Medeiros, B. C. (2012). Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia. LEUKEMIA, 26(5), 893-901.
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
Liedtke, M., Twist, C. J., Medeiros, B. C., Gotlib, J. R., Berube, C., & Coutre, S. E. (2012). Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97(1), 30-37.
Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer
Lee, R., Wen, A., & Berube, C. (2011). Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 68(9), 814-817.
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience
Kohrt, H. E., Patel, S., Ho, M., Owen, T., Pollyea, D. A., & Medeiros, B. C. (2010). Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience. AMERICAN JOURNAL OF HEMATOLOGY, 85(11), 877-881.
Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9
Sagrieya, H., Berube, C., Wen, A., Ramakrishnan, R., Mir, A., & Altman, R. B. (2010). Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9. PHARMACOGENETICS AND GENOMICS, 20(7), 407-413.
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
Gotlib, J., Berube, C., Growney, J. D., Chen, C. C., George, T. I., & Coutre, S. E. (2005). Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. BLOOD, 106(8), 2865-2870.
Patient Comments
9 Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Nov 2014
Dr. Caroline Berube even her telling me about my weight, give me the power and I will not let her down.
SHC Patient, Oct 2014
You need a spot here for EXCELLENT because to call Dr. Berube' "very good" is negligent - she saved my life from AML and I am forever in her debt.
SHC Patient, Oct 2014
Dr. Berube has big a huge part of my recovery.
SHC Patient, Sep 2014
Dr. Berube went above & beyond to help me get the medication I needed & even personally called the insurance company to help make sure it was covered.
SHC Patient, Aug 2014
Dr. Berube has the patience of a saint. Very cautious and concerned. ALWAYS answers my endless list of questions. Worked hard to get me into NIH trial!
SHC Patient, Jul 2014
Dr. Berube is wonderful physician, kind, thoughtful, helpful.
SHC Patient, Jun 2014
If anyone I know needed this type of doctor I would INSIST that they see Dr. Berube.
SHC Patient, May 2014
Doctor Berube was all business not very personable at all nor very friendly. Her assistant was much more friendly and seemed more concerned about my health then her.
SHC Patient, May 2014
Dr. Berube is an exceptional care provider.